Nicotinamide for Skin Cancer Chemoprevention
The results of this cohort study suggest that there is a decreased risk of skin cancer among patients treated with nicotinamide, with the greatest effect seen when initiated after the first skin cancer.
Authors
- Lydia Yao
- Rachel Weiss
- Yaomin Xu (ORCID: https://orcid.org/0000-0002-3752-4006)
- Lee Wheless (ORCID: https://orcid.org/0000-0002-8162-5971)
- Jonathan C. Hwang (ORCID: https://orcid.org/0000-0001-6415-9369)
- Rebecca I. Hartman (ORCID: https://orcid.org/0000-0001-5559-9100)
- K. Maas
- Christopher Madden (ORCID: https://orcid.org/0000-0003-1154-177X)
- Kimberly F. Breglio
- Siwei Zhang (ORCID: https://orcid.org/0009-0005-0873-5217)
- K. Knox
Institutions
- Brigham and Women's Hospital (US)
- State University of New York (US)
- University of Pittsburgh (US)
- SUNY Downstate Health Sciences University (US)
- Vanderbilt University (US)
- University of Michigan (US)
- VA Boston Healthcare System (US)
- VA Tennessee Valley Healthcare System (US)
- Durham VA Medical Center (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2025-09-17
- DOI
- https://doi.org/10.1001/jamadermatol.2025.3238
- Citations
- 9
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 7.18